[PDF][PDF] Loncastuximab tesirine-lpyl 的临床研究进展
汪璐， 任燕， 丁子文， 张婧妍， 袁宜耘， 王俊龙， 倪娜 - 世界临床药物, 2022 - jwph.com.cn
… phase I study of adct-402(loncastuximab tesirine), a novel pyrrolobenzodiazepine-based
antibody-drug conjugate, in relapsed/refractory B-cell non-hodgkin lymphoma[J]. Clin Cancer …
antibody-drug conjugate, in relapsed/refractory B-cell non-hodgkin lymphoma[J]. Clin Cancer …